We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Chinese API Makers Over Falsified Data, Improper Testing
FDA Warns Chinese API Makers Over Falsified Data, Improper Testing
The FDA is accusing two Chinese API manufacturers of doctoring laboratory results, with one cited for falsifying lab reports and the other for running both official and unofficial tests.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor